Review
Published on 07 May 2026
Antimycobacterial peptides as natural therapeutics for tuberculosis: mechanisms and structural features
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1769369
- 494 views
Type at least 3 characters
20 articles
articles
Review
Published on 23 Apr 2026
Microbial interactions of EDTA: recent advances and biological applications in the context of natural product modulation
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767602
- 908 views
Review
Published on 06 Apr 2026
Traditional medicine and natural product based therapeutics in gingivitis management and microbial interactions
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1764314
- 708 views
Review
Published on 25 Mar 2026
Antimicrobial peptides: emerging next-generation strategy for sustainable plant disease management
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1766594
- 892 views
Mini Review
Published on 26 Feb 2026
Beyond antibiotics: the expanding horizon of microbial natural products
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1768331
- 573 views
Review
Published on 24 Feb 2026
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767028
- 837 views
Review
Published on 10 Feb 2026
Natural product based approaches to overcome Candida glabrata and emerging AMR threats
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767032
- 1,074 views
Original Research
Published on 28 Jan 2026
Activity of Biocidin® against microbial biofilms
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1692653
- 2,562 views
Perspective
Published on 29 Apr 2025
Data transparency and reproducibility in health research: bridging the gap for early-career researchers
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1562002
- 2,999 views
- 1 citation
Original Research
Published on 15 Jan 2025
Analysis of engineered T7 bacteriophages containing genetic sequences encoding antimicrobial peptides
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1515874
- 3,616 views
- 5 citations
Original Research
Published on 24 Jun 2024
Genomic modifications for enhanced antibiotic production in rifamycin derivative-producing Amycolatopsis mediterranei S699 strains: focusing on rifQ and rifO genes
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1399139
- 5,407 views
- 2 citations
Original Research
Published on 08 May 2024
Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1362516
- 5,783 views
- 2 citations
Original Research
Published on 08 Apr 2024
Targeting synthesis of the Chromosome Replication Initiator Protein DnaA by antisense PNA-peptide conjugates in Escherichia coli
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2024.1384390
- 3,790 views
- 6 citations
Original Research
Published on 21 Aug 2023
Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1179354
- 4,504 views
- 11 citations
Original Research
Published on 17 Jul 2023
Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of Mycobacterium marinum
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1162941
- 2,879 views
- 2 citations
Original Research
Published on 12 Jul 2023
Screening Amazon rainforest plant extracts for antimicrobial activity: a 15-year commitment to the Brazilian biodiversity
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1122400
- 7,457 views
- 6 citations
Brief Research Report
Published on 22 Mar 2023
Antimicrobial activity of a new class of synthetic retinoid antibiotics and comparator agents against ocular staphylococci
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1101450
- 3,010 views
- 1 citation
Review
Published on 09 Feb 2023
Repurposing inhibitors of phosphoinositide 3-kinase as adjuvant therapeutics for bacterial infections
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1135485
- 3,401 views
- 11 citations
Mini Review
Published on 30 Jan 2023
Resistance-resistant antibacterial treatment strategies
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2023.1093156
- 9,876 views
- 18 citations
Original Research
Published on 09 Sep 2022
Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2022.928365
- 3,456 views
- 3 citations